secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0001575872-23-000800
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition extends business combination deadline to June 19, 2023; Estrella deposits $45,511
--------------------------------------------------------------------------------

- Company extended deadline to complete initial business combination from May 19 to June 19, 2023.
- Estrella Biopharma deposited $45,511 ($0.05 per public share) into trust account for the extension.
- Deposit evidenced by unsecured zero-interest promissory note; convertible into shares at $10.00 per share.
- Note payable upon consummation of business combination or within 5 business days of termination.
- Extension is pursuant to existing merger agreement with Estrella Biopharma, dated September 30, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000800/0001575872-23-000800-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000800/uptd-20230303.htm
  HTML page:      https://secwatch.observer/filing/0001575872-23-000800

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer